Vantage with Palki Sharma | N18G Eli Lilly’s blockbuster diabetes drug, Mounjaro, has officially launched in India — sparking a new battle for the country’s waistline. This comes as the country gears ...

The Bryan County Sheriff's Office says that one person has died following an incident at the Hyundai Megasite. Officials ...

I’m one of the millions of people trying to keep the weight off without taking expensive drugs like Mounjaro or Ozempic for ...

Join a real-time written chat with WSJ’s Bradley Olson on Monday, March 24, from 3 p.m. to 4 p.m. ET. WSJ subscribers can ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

The star, who turned 63 on Friday, has been taking the popular medication to help manage the chronic disease which affects how the body uses glucose (sugar) for energy.

GLP-1 (glucagon-like peptide) medications, such as Ozempic and Wegovy, have seen a surge in popularity over the past few ...

Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re still available on some websites.

There are so many false promises online when it comes to losing weight. Here are my top weight loss technologies that ...

Destination XL Group struggles with negative trends and a shrinking market. Find out why DXLG stock is a Hold, with no reversal in sight for its sales issues.

Pharma giant Eli Lilly has launched a new anti-obesity and diabetes drug in India called Mounjaro. But should you take ...